Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

Tune into the virtual program at 12:30pm PT HERE

Overview:

The gap between the efficacy of older anti-VEGF agents in clinical trials vs real-world practice helped lead to an evolution in treat-and-extend approaches with newer agents for the treatment of patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

In this program, a panel of expert faculty will discuss best practices in identifying nAMD and DME (with the audience participating in diagnosing cases); optimizing treat-and-extend strategies with newer anti-VEGF agents; and providing collaborative care from optometrists and retina specialists for these patients.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Integrate effective diagnostic tools and imaging techniques in the assessment of patients with nAMD
• Integrate effective diagnostic tools and imaging techniques in the assessment of patients with DME
• Apply evidence-based guidance for treat-and-extend protocols for the management of nAMD
• Apply evidence-based guidance for treat-and-extend protocols for the management of DME
• Formulate an effective multidisciplinary patient management strategy to enhance communication and collaboration between optometrists and retina specialists

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is accredited by COPE to provide continuing education to optometrists.

Physicians’ Education Resource^®, LLC, designates this activity for a maximum of 1.0 COPE credits.